Patients considering GLP-1 medications should consult their healthcare provider to discuss whether pharmaceutical intervention is appropriate for their specific clinical situation, including consideration of cardiovascular risk factors, degree of hyperglycemia, and previous response to lifestyle interventions
89 Using the recommended, less-frequent titration schedule of longer-acting basal insulins allows the insulin to reach steady state and avoids this concern
Potential benefits may include: Support for healthy blood vessel function Improvements in certain cardiovascular risk factors Reduced risk of major cardiovascular events in specific patient populations The exact benefits vary based on individual health conditions and medical history
Such limitations impact the performance of quantitative assays used to assess pharmacodynamics throughout drug development
This active component is produced in the gut
The practical result is a compound that reduces energy intake through appetite suppression while simultaneously increasing energy expenditure